Production shutdowns and impact on business performance due to the spread of COVID-19
First written in FY2020. 7 of 11 entries say "Worsened", first in FY2021-Q1. Latest entry: FY2024-Q1.
No other company in this theme has enough history to compare yet.
- FY2024-Q1MitigatedAnnual report
「Sentiment has improved as economic activity normalizes in the post-pandemic environment.」
The assessment has changed from the previous situation centered on the stagnation of economic activity caused by the spread of COVID-19 to one in which economic activity is normalizing and sentiment is improving in the post-pandemic environment. - FY2023ReframedAnnual report
「④ Epidemics and diseases For epidemics and diseases, we are implementing measures including collecting and disseminating information on diseases and infection status, issuing prevention announcements and conducting regular training for employees, implementing travel restrictions, and stockpiling pharmaceuticals and other supplies.」
Risk measures have been expanded beyond disclosures focused on COVID-19 to include information gathering, training, travel restrictions, and pharmaceutical stockpiling covering epidemics and diseases in general. - FY2022WorsenedAnnual report
「The outlook remains uncertain due to the sharp increase in infections since the end of 2021, the cooling of China's real estate market, restrictions on economic activity under the zero-COVID policy, and the impact of Russia's invasion of Ukraine, among other factors.」
The renewed spread of infections, restrictions on economic activity under the zero-COVID policy, and spillover factors affecting overseas economies have added to the continuing uncertainty related to the pandemic. - FY2022-Q3WorsenedAnnual report
「The outlook remains uncertain, as COVID-19 infections have resurged in Southeast Asia, while the growth in production activity in China has slowed against a backdrop of environmental regulations and restrictions on real estate development, among other factors.」
The disclosure states that the renewed spread of COVID-19 in Southeast Asia and its impact on economic activity are continuing. - FY2022-Q2WorsenedAnnual report
「The automotive industry in which the Group operates had been on a recovery trend from the pandemic, but automakers have been forced to adjust production due to the global semiconductor shortage and parts supply shortages caused by the renewed spread of COVID-19 in Southeast Asia.」
Although a recovery trend from the pandemic was noted, semiconductor shortages and parts supply shortages caused by the renewed spread of infections in Southeast Asia have led automakers to adjust production. - FY2022-Q1MitigatedAnnual report
「Although economic activity is expected to recover as vaccination against COVID-19 expands and various policies take effect, the situation remains unpredictable, including due to the risk of the spread of variants.」
Sales and performance improved year on year as economic activity was expected to recover due to expanded vaccination and the effects of government policies, but the risk of variant spread continues. - FY2021WorsenedAnnual report
「Due to the spread of COVID-19, automakers that are customers of the Group have suspended production at their plants in Japan and overseas. As a result, the Group has also been forced to suspend or adjust production at its various plants.」
The suspension and adjustment of production at automakers and the Group's own plants due to the spread of COVID-19 remained a risk throughout the fiscal year. - FY2021-Q3WorsenedAnnual report
「The renewed spread of COVID-19 continues to heighten uncertainty about the outlook. Overseas, COVID-19 infections also continue to spread, raising concerns about stagnation in economic activity and its prolongation」
The renewed spread and continued prevalence of COVID-19 continue to affect economic conditions and economic activity in Japan and overseas. - FY2021-Q2WorsenedAnnual report
「In Europe, COVID-19 infections are rising sharply again, and uncertainty remains due to factors including the impact on economic activity from tighter restrictions and deep-rooted US-China tensions over the pandemic. The outlook therefore remains uncertain.」
The disclosure notes a renewed increase in COVID-19 infections in Europe and tighter restrictions, with the impact on overseas economies continuing. - FY2021-Q1WorsenedAnnual report
「In the automotive industry in which our group operates, vehicle sales in the domestic market declined sharply due to sluggish consumption caused by the spread of COVID-19. Overseas, sales in China have been recovering as the COVID-19 situation has improved and fiscal support policies for new-energy vehicles have taken effect. However, in the U.S. and other markets, consumption has remained sluggish due to the spread of COVID-19, and sales have generally continued to decline.」
The decline in domestic and overseas vehicle sales resulting from the spread of COVID-19 was reflected in the results for the current quarter, with revenue down 47.8% year on year and an operating loss of ¥5,542 million. - FY2020First statedAnnual report
「Due to the spread of COVID-19, domestic and overseas plants of automakers to which our group supplies products have halted production. As a result, our group's plants have also been forced to halt production or adjust production levels. We believe this situation is highly likely to have a material impact on our group's financial position, operating results and cash flow from the fiscal year ending March 2021 onward.」
The company has newly disclosed, as an independent risk, that the spread of COVID-19 had already resulted in production stoppages and production adjustments at automakers and its own plants, with the potential for a material impact on its financial position, operating results and cash flow from the fiscal year ending March 2021 onward.